Minfeng Zhang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
TACE plus PD-1 inhibitor (Camrelizumab) treatment for bridging to tumor resection in HCC: Case reports.
Journal: Clinics and research in hepatology and gastroenterology
Published: January 12, 2021
The CD68+ macrophages to CD8+ T-cell ratio is associated with clinical outcomes in hepatitis B virus (HBV)-related hepatocellular carcinoma.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: June 01, 2020
LncRNA FOXD2-AS1 as a competitive endogenous RNA against miR-150-5p reverses resistance to sorafenib in hepatocellular carcinoma.
Journal: Journal of cellular and molecular medicine
Published: February 02, 2019
lncRNA AK054386 Functions as a ceRNA to Sequester miR-199 and Induce Sustained Endoplasmic Reticulum Stress in Hepatic Reperfusion Injury.
Journal: Oxidative medicine and cellular longevity
Published: November 14, 2018
Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: July 12, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026